✦ LIBER ✦

Comparison of pemetrexed plus cisplatin with other first-line doublets in advanced non-small cell lung cancer (NSCLC): A combined analysis of three phase 3 trials

✍ Scribed by Treat, Joseph; Scagliotti, Giorgio V.; Peng, Guangbin; Monberg, Matthew J.; Obasaju, Coleman K.; Socinski, Mark A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1BA Phase III study of pemetrexed plus c

✍ C. Manegold; R. Digumarti; M. Zukin; F. de Marinis; A. Mellemgaard; D. Gandara; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 40 KB

An indirect comparison of bevacizumab pl

✍ John Wen-Cheng CHANG; Sumitra THONGPRASERT; Elaine WRIGHT; Kenneth TSANG; Heung 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 409 KB

A phase II trial of oral UFT plus cispla

✍ Saito, Junichi; Nakai, Yushi; Saijo, Yasuo; Nukiwa, Toshihiro; Koinumaru, Sadahi 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 87 KB

A Phase II Trial of First-line Bevacizum

✍ Z. Skaff; A. Hageboutros; K. Krieger; S. Coakley; R. Somer; J. Stevenson 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 43 KB

Phase III randomized trial of docetaxel

📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 494 KB

A phase II study of UFT plus cisplatin (

✍ Nakanishi, Y; Fujita, M; Ninomiya, K; Motohiro, A; Kanegae, H; Osaki, S; Watanab 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 234 KB